BRIEF-CVS Health to increase access to FDA-approved nasal naloxone for patients without insurance By: Reuters: Company News July 29, 2016 at 10:51 AM EDT * Says to increase access to FDA-approved nasal naloxone for patients without insurance Read More >> Related Stocks: CVS Health Corp